Member-only story

I’m Aware That I’m Rare: David Harris(356)

phaware global association®
8 min readDec 15, 2020

--

The phaware® interview

David F. Harris founded Insight & Measurement and provides research, training and speaking to the industry.

In this episode, he discusses the qualitative and quantitative work that he conducts with PAH patients, so that people who get invited to be part of these types of studies have some understanding of what actually the process is like and what gets done with those results.

My name is David Harris. I run a company called Insight & Measurement, and we do a lot of work in rare diseases and in healthcare. My background has always been in healthcare. I worked in a hospital many years ago and I was director of research methods at the big pharma company called GlaxoSmithKline followed by another company called Merz North America. I’ve done a lot of work in the area of pulmonary arterial hypertension. I’ve had the good fortune of being able to work with the people at phaware global association to really help advance the perspective of patients for pharma companies and for device companies.

--

--

phaware global association®
phaware global association®

Written by phaware global association®

Are You #phaware? Pulmonary hypertension (PH) is a rare, life-threatening disease affecting the arteries of the lungs. www.phaware.global

No responses yet